NHS procurement process

Market Access

The NHS finds itself in a very challenging place post-COVID, with unprecedented waiting lists, stretched finances, and a staffing crisis.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.